PharmaShots | Incisive News in 3 Shots

Subscribe Now

IMpower130 study

Roche Reports Results of P-III IMpower130 study of Tecentriq (atezolizumab) for 1L Treatment in Advance NSCLC

Roche Reports Results of P-III IMpower130 study of Tecentriq (atezolizumab) for 1L Treatment in Advance NSCLC

October 22, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us